Cargando…
Test–retest reproducibility of cannabinoid-receptor type 1 availability quantified with the PET ligand [(11)C]MePPEP
BACKGROUND: Endocannabinoids are involved in normal cognition, and dysfunction in cannabinoid-receptor-mediated neurotransmission has been suggested in a variety of neurological and psychiatric pathologies. The type 1 cannabinoid receptor (CB(1)) is widely expressed in the human central nervous syst...
Autores principales: | Riaño Barros, Daniela A., McGinnity, Colm J., Rosso, Lula, Heckemann, Rolf A., Howes, Oliver D., Brooks, David J., Duncan, John S., Turkheimer, Federico E., Koepp, Matthias J., Hammers, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283194/ https://www.ncbi.nlm.nih.gov/pubmed/24736184 http://dx.doi.org/10.1016/j.neuroimage.2014.04.020 |
Ejemplares similares
-
Test-retest reproducibility of quantitative binding measures of [(11)C]Ro15-4513, a PET ligand for GABA(A) receptors containing alpha5 subunits
por: McGinnity, Colm J., et al.
Publicado: (2017) -
Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors
por: Bhattacharyya, Sagnik, et al.
Publicado: (2017) -
On brain atlas choice and automatic segmentation methods: a comparison of MAPER & FreeSurfer using three atlas databases
por: Yaakub, Siti Nurbaya, et al.
Publicado: (2020) -
Simplifying [(18)F]GE-179 PET: are both arterial blood sampling and 90-min acquisitions essential?
por: McGinnity, Colm J., et al.
Publicado: (2018) -
Using [(11)C]Ro15 4513 PET to characterise GABA-benzodiazepine receptors in opiate addiction: Similarities and differences with alcoholism
por: Lingford-Hughes, Anne, et al.
Publicado: (2016)